MGMT and glioblastoma: These results suggested that EGF improves the sensitivity of TMZ-R tumors to TMZ, implicitly pointing to the deficiency of EGFR signaling in the endowment of CSC chemoresistance in glioblastomas in an MGMT-independent context.